Skip to main content
SpringerLink
Log in

cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant

  • Correspondence
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bayliss J, Mukherjee P, Lu C, Jain SU, Chung C, Martinez D, Sabari B, Margol AS, Panwalkar P, Parolia A et al (2016) Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas. Sci Transl Med 8:366ra161. https://doi.org/10.1126/scitranslmed.aah6904

    Article  PubMed  PubMed Central  Google Scholar 

  2. Bechet D, Gielen GG, Korshunov A, Pfister SM, Rousso C, Faury D, Fiset PO, Benlimane N, Lewis PW, Lu C et al (2014) Specific detection of methionine 27 mutation in histone 3 variants (H3K27M) in fixed tissue from high-grade astrocytomas. Acta Neuropathol 128:733–741. https://doi.org/10.1007/s00401-014-1337-4

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Gessi M, Capper D, Sahm F, Huang K, von Deimling A, Tippelt S, Fleischhack G, Scherbaum D, Alfer J, Juhnke BO et al (2016) Evidence of H3 K27M mutations in posterior fossa ependymomas. Acta Neuropathol 132:635–637. https://doi.org/10.1007/s00401-016-1608-3

    Article  PubMed  Google Scholar 

  4. Hochart A, Escande F, Rocourt N, Grill J, Koubi-Pick V, Beaujot J, Meignan S, Vinchon M, Maurage CA, Leblond P (2015) Long survival in a child with a mutated K27M-H3.3 pilocytic astrocytoma. Ann Clin Transl Neurol 2:439–443. https://doi.org/10.1002/acn3.184

    Article  PubMed  PubMed Central  Google Scholar 

  5. Johnson A, Severson E, Gay L, Vergilio JA, Elvin J, Suh J, Daniel S, Covert M, Frampton GM, Hsu S et al (2017) Comprehensive genomic profiling of 282 pediatric low- and high-grade gliomas reveals genomic drivers, tumor mutational burden, and hypermutation signatures. Oncologist. https://doi.org/10.1634/theoncologist.2017-0242

    PubMed Central  Google Scholar 

  6. Kleinschmidt-DeMasters BK, Donson A, Foreman NK, Dorris K (2017) H3 K27M mutation in gangliogliomas can be associated with poor prognosis. Brain Pathol 27:846–850. https://doi.org/10.1111/bpa.12455

    Article  CAS  PubMed  Google Scholar 

  7. Louis DN, Aldape K, Brat DJ, Capper D, Ellison DW, Hawkins C, Paulus W, Perry A, Reifenberger G, Figarella-Branger D et al (2017) Announcing cIMPACT-NOW: the consortium to inform molecular and practical approaches to CNS tumor taxonomy. Acta Neuropathol 133:1–3. https://doi.org/10.1007/s00401-016-1646-x

    Article  PubMed  Google Scholar 

  8. Louis DN, Aldape K, Brat DJ, Capper D, Ellison DW, Hawkins C, Paulus W, Perry A, Reifenberger G, Figarella-Branger D et al (2017) cIMPACT-NOW (the consortium to inform molecular and practical approaches to CNS tumor taxonomy): a new initiative in advancing nervous system tumor classification. Brain Pathol 27:851–852. https://doi.org/10.1111/bpa.12457

    Article  PubMed  Google Scholar 

  9. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2016) World Health Organization histological classification of tumours of the central nervous system. International Agency for Research on Cancer, Lyon

    Google Scholar 

  10. Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820. https://doi.org/10.1007/s00401-016-1545-1

    Article  PubMed  Google Scholar 

  11. Louis DN, Wesseling P, Paulus W, Giannini C, Batchelor TT, Cairncross JG, Capper D, Figarella-Branger D, Lopes MB, Wick W et al (2018) cIMPACT-NOW update 1: not otherwise specified (NOS) and not elsewhere classified (NEC). Acta Neuropathol. https://doi.org/10.1007/s00401-018-1808-0

    Google Scholar 

  12. Morita S, Nitta M, Muragaki Y, Komori T, Masui K, Maruyama T, Ichimura K, Nakano Y, Sawada T, Koriyama S et al (2017) Brainstem pilocytic astrocytoma with H3 K27M mutation: case report. J Neurosurg. https://doi.org/10.3171/2017.4.JNS162443

    Google Scholar 

  13. Orillac C, Thomas C, Dastagirzada Y, Hidalgo ET, Golfinos JG, Zagzag D, Wisoff JH, Karajannis MA, Snuderl M (2016) Pilocytic astrocytoma and glioneuronal tumor with histone H3 K27M mutation. Acta Neuropathol Commun 4:84. https://doi.org/10.1186/s40478-016-0361-0

    Article  PubMed  PubMed Central  Google Scholar 

  14. Pages M, Beccaria K, Boddaert N, Saffroy R, Besnard A, Castel D, Fina F, Barets D, Barret E, Lacroix L et al (2018) Co-occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma. Brain Pathol 28:103–111. https://doi.org/10.1111/bpa.12473

    Article  CAS  PubMed  Google Scholar 

  15. Pratt D, Natarajan SK, Banda A, Giannini C, Vats P, Koschmann C, Mody R, Chinnaiyan A, Venneti S (2018) Circumscribed/non-diffuse histology confers a better prognosis in H3K27M-mutant gliomas. Acta Neuropathol 135:299–301. https://doi.org/10.1007/s00401-018-1805-3

    Article  CAS  PubMed  Google Scholar 

  16. Ryall S, Guzman M, Elbabaa SK, Luu B, Mack SC, Zapotocky M, Taylor MD, Hawkins C, Ramaswamy V (2017) H3 K27M mutations are extremely rare in posterior fossa group A ependymoma. Childs Nerv Syst 33:1047–1051. https://doi.org/10.1007/s00381-017-3481-3

    Article  PubMed  Google Scholar 

  17. Tanboon J, Williams EA, Louis DN (2016) The diagnostic use of immunohistochemical surrogates for signature molecular genetic alterations in gliomas. J Neuropathol Exp Neurol 75:4–18. https://doi.org/10.1093/jnen/nlv009

    Article  CAS  PubMed  Google Scholar 

  18. Zhang J, Wu G, Miller CP, Tatevossian RG, Dalton JD, Tang B, Orisme W, Punchihewa C, Parker M, Qaddoumi I et al (2013) Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat Genet 45:602–612. https://doi.org/10.1038/ng.2611

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This paper has been reviewed by the Steering Committee and Clinical Advisory Panel of cIMPACT-NOW [7, 8] and by the International Society of Neuropathology Executive.

Author information

Authors and Affiliations

  1. Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA

    David N. Louis

  2. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA

    Caterina Giannini

  3. Department of Neuropathology, Berlin Institute of Health, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany

    David Capper

  4. Institute of Neuropathology, University Hospital Münster, Pottkamp 2, 48149, Münster, Germany

    Werner Paulus

  5. Aix-Marseille Univ, APHM, CNRS, INP, Inst Neurophysiopathol, Hôpital de la Timone, Service d’Anatomie Pathologique et de Neuropathologie, Marseille, France

    Dominique Figarella-Branger

  6. Departments of Pathology and Neurological Surgery, University of Virginia, Charlottesville, VA, 22908, USA

    M. Beatriz Lopes

  7. Departments of Neurology, Radiation Oncology and Division of Hematology/Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA

    Tracy T. Batchelor

  8. Charbonneau Cancer Institute, University of Calgary, Calgary, AB, T2N4Z6, Canada

    J. Gregory Cairncross

  9. The Brain Tumor Center at Erasmus MC Cancer Center, Rotterdam, The Netherlands

    Martin van den Bent

  10. Neurology Clinic and National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany

    Wolfgang Wick

  11. Clinical Cooperation Unit Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany

    Wolfgang Wick

  12. German Cancer Consortium (DKTK) Core Center Heidelberg, Heidelberg, Germany

    Wolfgang Wick

  13. Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands

    Pieter Wesseling

  14. Department of Pathology, Princess Máxima Center for Pediatric Oncology, University Medical Center Utrecht, Utrecht, The Netherlands

    Pieter Wesseling

Authors
  1. David N. Louis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Caterina Giannini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David Capper
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Werner Paulus
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dominique Figarella-Branger
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Beatriz Lopes
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tracy T. Batchelor
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J. Gregory Cairncross
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Martin van den Bent
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Wolfgang Wick
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Pieter Wesseling
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David N. Louis.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Louis, D.N., Giannini, C., Capper, D. et al. cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant. Acta Neuropathol 135, 639–642 (2018). https://doi.org/10.1007/s00401-018-1826-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-018-1826-y

Search

Navigation